Since recent literature suggests aberrant genomic expression of axonal guidance cue molecules in cancer [25], we went ahead and analyzed the copy number variation of SEMA5A in PC cases using The Cancer Genome Atlas (TCGA) Database. This evidence concerns the gene SEMA5A and cancer.